PCSK9 loss-of-function variants and Lp(a) phenotypes among black US adults[S]

Mefford, MT; Marcovina, SM; Bittner, V; Cushman, M; Brown, TM; Farkouh, ME; Tsimikas, S; Monda, KL; Lopez, JAG; Muntner, P; Rosenson, RS

Mefford, MT (reprint author), Kaiser Permante Southern Calif, Dept Res & Evaluat, Pasadena, CA 91107 USA.; Mefford, MT (reprint author), Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35294 USA.

JOURNAL OF LIPID RESEARCH, 2019; 60 (11): 1946

Abstract

The pharmacologic inhibition of proprotein convertase subtilisin-kexin type 9 (PCSK9) lowers lipoprotein (a) [Lp(a)] concentrations. However, the impa......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索